超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

法國SkinEthic   
全球性的生產和銷售人體表皮和上皮組織的企業，其產品供不同行業作生物體外測試之用。

Relevant, Reliable, Ready-to-use and Robust skin and eye, validated & REACh compliant alternatives, within respecting the ethical human diversity.

The purpose of the company is to offer to the global scientific community – academic and industry – in vitro solutions for safety testing and efficacy profiling to support research and development activities.

COMPANY OVERVIEW

SKINETHIC Laboratories provides our worldwide clients RELIABLE AND RELEVANT IN VITRO TOOLS FOR SAFETY AND EFFICACY PROFILING

SkinEthic Laboratories, world leader in tissue engineering, is partnering with cosmetical, pharmaceutical and chemical industries to develop relevant and reliable safety and efficacy tests for decision making during research and development phases. Some screening tests are already referenced and validated as alternatives to animal use, and others are in the process of validation. Developed in the early 90, our unique cell culture process allows to mass produce in vitro various models of reconstructed human tissues with well characterized histology, functionality and ultrastructure features. The production unit is geared to serve every week our clients with thousands of human tissues.

Our product line includes:
? Reconstructed human epidermis,
? Reconstructed human epidermis with melanocytes (with a different tanning degree from phototype II to VI),
? Reconstructed Human Corneal Epithelium, Reconstructed Human mucosa: Oral, Gingival, and Vaginal Epithelium.

OUR MISSION

SkinEthic Laboratories’ philosophy is based on 3 main commitments:
to develop and produce robust and valuable reproducible models.
to ensure a training and education of using validated protocols allowing the screening of large numbers of raw materials, active ingredients and finished products being either in a solid, liquid, powder, cream or gel form.
to support our users and partners in providing a dedicated and customized service.